Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach
Molecular Therapy 24, 1888 (November 2016). doi:10.1038/mt.2016.191
Authors: Jacques P Tremblay, Jean-Paul Iyombe-Engembe, Benjamin Duchêne & Dominique L Ouellet
from Cancer via ola Kala on Inoreader http://ift.tt/2gKHR9s
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου